Clinical Trial Update: Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the combination of docetaxel and flavopiridol in patients with locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Flavopiridol (alvocidib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED